Keybanc analyst Sean Eastman downgrades EMCOR Gr (NYSE:EME) from Overweight to Sector Weight.
GlucoTrack Announces Shareholder Update
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that Paul V. Goode, PhD,